Miami Cancer Institute

Miami Cancer Institute to Host Inaugural Precision Oncology Symposium

January 9, 2023

MIAMI, FL – January 9, 2023 – Miami Cancer Institute, part of Baptist Health South Florida, announced it is hosting its inaugural Precision Oncology Symposium February 3-4, 2023, at the Biltmore Hotel in Coral Gables, Fla. The educational symposium is designed to provide an overview about the most recent advances in the treatment of solid tumors – including lung cancer, breast cancer, gastrointestinal tumors, genitourinary tumors, head and neck tumors, melanoma, sarcoma, and brain tumors – with novel targeted agents and treatment combinations.

“We couldn’t be more excited to host the inaugural Miami Cancer Institute Precision Oncology Symposium here in South Florida,” said Manmeet Ahluwalia, M.D., M.B.A., the symposium’s director as well as Fernandez Family Foundation Endowed Chair In Cancer Research, Chief of Medical Oncology, Chief Scientific Officer, and Deputy Director of Miami Cancer Institute. “For the inaugural symposium the goal is to bring oncology leaders from around the country to Miami to discuss the latest advances in solid-tumor therapies with physicians in the South Florida community. Symposia like this one provide a unique opportunity to interact with key opinion leaders in the field, learn about the latest technologies, and connect with investigators leading the most cutting-edge clinical trials.”

Given the increase in the discovery of oncogenic-driven tumors over the past two decades, targeted treatments with novel agents have positively transformed the outcomes in cancer patients. However, clinical decision making and management have become more complex as a result. The Miami Cancer Institute Precision Oncology Symposium provides an opportunity for medical professionals to engage in thoughtful discussions with experts in these emerging fields in oncology.

“For the inaugural symposium we’ve invited key opinion leaders and oncologists who are on the cutting edge of cancer treatment from the most prestigious organizations across the nation,” said Ahluwalia. “They will summarize the evolving therapeutic strategies, provide updates on new molecular and targeted treatments, discuss the rationale for new targeted diagnostic and therapeutic strategies, and review the role and timing of diagnostic tests, molecular profiling, and potential combinations of targeted therapy treatment options.”

The symposium is directed toward oncologists, pathologists, radiation oncologists, palliative care staff, oncology, pharmacists, laboratory and other allied healthcare team members interested in the treatment of patients with solid tumor malignancies. Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians. Participants of the Precision Medicine Symposium will be able to claim CME credits when attending the symposium.

Those interested in attending the symposium can register at

For updates about the Miami Cancer Institute Precision Oncology Symposium, follow Miami Cancer Institute on Twitter at @MiamiCancerInst.




About Miami Cancer Institute

Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK. For more information, please visit

Miami Cancer Institute is part of Baptist Health Cancer Care, the largest cancer program in South Florida, with locations from the Florida Keys to the Palm Beaches.

About Baptist Health Cancer Care

Baptist Health Cancer Care is the largest cancer program in South Florida, providing local, out-of-state and international patients with the most advanced cancer care. With locations from the Florida Keys to the Palm Beaches, the program provides cancer patients access to a full array of innovative clinical trials, physicians dedicated to bringing discovery to the bedside, access to personalized cancer treatments and comprehensive patient support services — all delivered with unparalleled compassion. Baptist Health Cancer Care includes its state-of-the-art premier institutes, Baptist Health Miami Cancer Institute and Baptist Health Lynn Cancer Institute, with renowned subspecialized surgical oncologists, medical oncologists and radiation oncologists, and highly advanced technologies available to treat every common and rare cancer.


Baptist Health Cancer Care is part of Baptist Health, based in South Florida, providing care through a network of 12 hospitals as well as more than 150 outpatient facilities and physician practices, welcoming more than 1.5 million patients from around the world each year. Baptist Health Cancer Care is also Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, an alliance based on common standards of care and many shared clinical trials.


To learn more about Baptist Health Cancer Care, visit


Language Preference / Preferencia de idioma

I want to see the site in English

Continue In English

Quiero ver el sitio en Español

Continuar en español